Combination Chemotherapy in Treating Young Patients With Langerhans Cell Histiocytosis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Kenneth L. McClain, MD, PhD
Texas Children's Cancer Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
33 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital de Pediatria Garrahan
Buenos Aires, Buenos Aires, Argentina
- St. Anna Children'S Hospital
Vienna, Austria
- Hospital for Sick Children
Toronto, Ontario, Canada
- Chr Hotel Dieu
Nantes, France
- University Medical Center Hamburg - Eppendorf
Hamburg, Germany
- Our Lady'S Hospital for Sick Children Crumlin
Dublin, Ireland
- Fondazione I.R.C.C.S. Policlinico San Matteo
Pavia, Italy
- Karolinska University Hospital - Solna
Stockholm, Sweden
- Birmingham Children'S Hospital
Birmingham, England, United Kingdom
- Institute of Child Health at University of Bristol
Bristol, England, United Kingdom
- Addenbrooke'S Hospital
Cambridge, England, United Kingdom
- Leeds Cancer Centre at St. James'S University Hospital
Leeds, England, United Kingdom
- Children'S Cancer and Leukaemia Group
Leicester, England, United Kingdom
- Leicester Royal Infirmary
Leicester, England, United Kingdom
- Royal Liverpool Children'S Hospital, Alder Hey
Liverpool, England, United Kingdom
- Great Ormond Street Hospital for Children
London, England, United Kingdom
- Royal London Hospital
London, England, United Kingdom
- Royal Manchester Children'S Hospital
Manchester, England, United Kingdom
- Sir James Spence Institute of Child Health at Royal Victoria Infirmary
Newcastle upon Tyne, England, United Kingdom
- Queen'S Medical Centre
Nottingham, England, United Kingdom
- Oxford Radcliffe Hospital
Oxford, England, United Kingdom
- Children'S Hospital - Sheffield
Sheffield, England, United Kingdom
- Southampton General Hospital
Southampton, England, United Kingdom
- Royal Marsden - Surrey
Sutton, England, United Kingdom
- Royal Belfast Hospital for Sick Children
Belfast, Northern Ireland, United Kingdom
- Royal Aberdeen Children'S Hospital
Aberdeen, Scotland, United Kingdom
- Royal Hospital for Sick Children
Edinburgh, Scotland, United Kingdom
- Royal Hospital for Sick Children
Glasgow, Scotland, United Kingdom
- Childrens Hospital for Wales
Cardiff, Wales, United Kingdom
- Masonic Cancer Center at University of Minnesota
Minneapolis, Minnesota, United States
- Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
- Vanderbilt Children'S Hospital
Nashville, Tennessee, United States
- Texas Children'S Cancer Center and Hematology Service at Texas Children'S Hospital
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2001
- Primary completion
- —
- Completion
- 30 Jun 2013
- Last update posted
- 10 Jan 2014
- Registered enrollment
- 376
- Registry id
- NCT00276757
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.